Liping Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liping Jiang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jianxiong Wu
Department of Hepatobiliary Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
1 shared publication Jinge Song
State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
1 shared publication- Li-Ying Sun
Department of Critical Liver Disease, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China
1 shared publication - Lina Zhao
State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
1 shared publication - Xiaohang Zhao
State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
1 shared publication Xiu Dong
State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
1 shared publication
Latest Publications
- Open Access
- 5 April 2022
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (4) , e793
Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma
- 5 April 2022
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (4) , e793
Open AccessIntegrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma